Exact Mass: 259.943
Exact Mass Matches: 259.943
Found 185 metabolites which its exact mass value is equals to given mass value 259.943,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
2,3,5-Trichloromaleylacetate
This compound belongs to the family of Medium-chain Keto Acids and Derivatives. These are keto acids with a 6 to 12 carbon atoms long side chain
beta-Fructofuranosidase
It is used in production of invert sugar from sucrose. Hydrolyses terminal non-reducing b-D-fructofuranoside residues in b-D-fructofuranosides. beta-Fructofuranosidase is found in many foods, some of which are soy bean, red beetroot, carrot, and french plantain.
3-Carboxy-7-chloro-1,2,4-benzothiadiazine-1,1-dioxide
3-chloro-2-fluoro-6-(trifluoromethyl)benzoyl chloride
carbarsone
C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent
Sulfonium,dimethyl(2-oxo-2-phenylethyl)-, bromide (1:1)
3-CHLORO-4-[(CHLOROACETYL)AMINO]PHENYL THIOCYANATE
3-Chloro-5-(trifluoromethyl)pyridine-2-sulfonamide
4,7-Dichloro-1,3-dihydro-1,3-dioxo-5-isobenzofurancarboxylic acid
3-(2,6-dichloropyridin-4-yl)-4-methyl-1H-1,2,4-triazole-5-thione
5-BROMO-2,3-DIHYDROBENZO[B]FURAN-7-CARBONYL CHLORIDE
Acamprosate calcium
Acamprosate calcium(Campral EC) is a GABA receptor agonist and modulator of glutamatergic systems; reduces alcohol consumption in animal models of alcohol addiction. IC50 value: Target: GABA receptor Acamprosate, or N-acetyl homotaurine, is an N-methyl-D-aspartate receptor modulator approved by the Food and Drug Administration (FDA) as a pharmacological treatment for alcohol dependence.Acamprosate has low bioavailability, but also has an excellent tolerability and safety profile. In comparison with naltrexone and disulfiram, which are the other FDA-approved treatments for alcohol dependence, acamprosate is unique in that it is not metabolized by the liver and is also not impacted by alcohol use, so can be administered to patients with hepatitis or liver disease (a common comorbid condition among individuals with alcohol dependence) and to patients who continue drinking alcohol.
